Research Article

[Retracted] Analysis of the Clinical Efficacy of Azacytidine + Venetoclax in the Treatment of Elderly Patients with Relapsed Refractory Acute Myeloid Leukemia

Table 4

Immunological parameters ().

GroupnCD4+ (%)CD3+ (%)CD4+/CD8+
BeforeAfterBeforeAfterBeforeAfter

Treatment group1036.89 ± 2.3431.56 ± 5.7850.26 ± 5.4538.45 ± 5.161.50 ± 0.261.32 ± 0.25
Control group1037.01 ± 1.6932.02 ± 6.4149.78 ± 4.3239.02 ± 4.471.52 ± 0.311.34 ± 0.29
T0.1310.1690.2180.2640.1560.165
0.8970.8680.8300.7950.8780.871